Intratumoral DNA-Based Delivery of Checkpoint-Inhibiting Antibodies and Interleukin 12 Triggers T Cell Infiltration and Anti-tumor Response

In the MC38 tumor model, combined administration of plasmids encoding IL-12 and an anti-PD-1 antibody induced significant anti-tumor responses, yet similar to the monotherapies.